Realized impact of COVID-19 related disruptions on the National Bowel Cancer Screening Program.
Matthew P IrwinTrisha DuttaMaxwell Andrew JamborMatthew J MorganCatherine E TurnerYicong LiangPublished in: ANZ journal of surgery (2024)
This study presents the most comprehensive analysis of the realized impact of COVID-19 on the NBCSP. Catch-up screening would be best targeted at Australians from rural and lower socioeconomic areas where participation remains low. Streamlined referral pathways and additional colonoscopy provisioning is required as less than two thirds of screen positive patients receive a colonoscopy within the recommended 120 days.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- quality improvement
- ejection fraction
- chronic kidney disease
- newly diagnosed
- south africa
- prognostic factors
- papillary thyroid
- squamous cell carcinoma
- young adults
- cancer therapy
- respiratory syndrome coronavirus
- patient reported outcomes
- squamous cell
- childhood cancer
- drug induced